Search terms included combinations of GLP-1 receptor agonist, semaglutide, liraglutide, tirzepatide, cutaneous side effects, dermatology, hidradenitis, psoriasis, bullous pemphigoid, facial aging, and plastic surgery. Of 260 articles initially identified, 155 were included on the basis of predefined eligibility criteria prioritizing randomized controlled trials, observational studies, systematic reviews, regulatory reports, and clinically relevant case series in adult populations
Localized irritation, redness, or tenderness at injection site
A months worth of GLP-1 patches can cost you $15 or less
MakoRxs IHM strategy is a carve-out that can be implemented at any time for your plans, and there is no need to change the existing plan structure